Durrant LG - Search Results

1

Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.

Pearson JRD, Cuzzubbo S, McArthur S, Durrant LG, Adhikaree J, Tinsley CJ, Pockley AG, McArdle SEB. Pearson JRD, et al. Among authors: durrant lg. Front Immunol. 2020 Oct 15;11:582106. doi: 10.3389/fimmu.2020.582106. eCollection 2020. Front Immunol. 2020. PMID: 33178210 Free PMC article. Review.

2

Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice.

Saif JM, Vadakekolathu J, Rane SS, McDonald D, Ahmad M, Mathieu M, Pockley AG, Durrant L, Metheringham R, Rees RC, McArdle SE. Saif JM, et al. Eur J Immunol. 2014 Apr;44(4):994-1004. doi: 10.1002/eji.201343863. Epub 2014 Mar 7. Eur J Immunol. 2014. PMID: 24338683 Free article.

3

Helicase antigen (HAGE)-derived vaccines induce immunity to HAGE and ImmunoBody®-HAGE DNA vaccine delays the growth and metastasis of HAGE-expressing tumors in vivo.

Nagarajan D, Pearson J, Brentville V, Metheringham R, Pockley AG, Durrant L, McArdle SE. Nagarajan D, et al. Immunol Cell Biol. 2021 Oct;99(9):972-989. doi: 10.1111/imcb.12485. Epub 2021 Sep 19. Immunol Cell Biol. 2021. PMID: 34105800

4

A Novel HAGE/WT1-ImmunoBody^® Vaccine Combination Enhances Anti-Tumour Responses When Compared to Either Vaccine Alone.

Almshayakhchi R, Nagarajan D, Vadakekolathu J, Guinn BA, Reeder S, Brentville V, Metheringham R, Pockley AG, Durrant L, McArdle S. Almshayakhchi R, et al. Front Oncol. 2021 Jun 28;11:636977. doi: 10.3389/fonc.2021.636977. eCollection 2021. Front Oncol. 2021. PMID: 34262856 Free PMC article.

5

Cancer Vaccines, Adjuvants, and Delivery Systems.

Paston SJ, Brentville VA, Symonds P, Durrant LG. Paston SJ, et al. Among authors: durrant lg. Front Immunol. 2021 Mar 30;12:627932. doi: 10.3389/fimmu.2021.627932. eCollection 2021. Front Immunol. 2021. PMID: 33859638 Free PMC article. Review.

6

Vaccine Can Induce CD4-Mediated Responses to Homocitrullinated Peptides via Multiple HLA-Types and Confer Anti-Tumor Immunity.

Cook K, Xue W, Atabani S, Symonds P, Al Omari A, Daniels I, Shah S, Choudhury RH, Weston D, Metheringham R, Brentville V, Durrant L. Cook K, et al. Front Immunol. 2022 Apr 8;13:873947. doi: 10.3389/fimmu.2022.873947. eCollection 2022. Front Immunol. 2022. PMID: 35464453 Free PMC article.

7

Structural biology of antibody recognition of carbohydrate epitopes and potential uses for targeted cancer immunotherapies.

Dingjan T, Spendlove I, Durrant LG, Scott AM, Yuriev E, Ramsland PA. Dingjan T, et al. Among authors: durrant lg. Mol Immunol. 2015 Oct;67(2 Pt A):75-88. doi: 10.1016/j.molimm.2015.02.028. Epub 2015 Mar 7. Mol Immunol. 2015. PMID: 25757815 Review.

8

Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy.

Cook KW, Xue W, Symonds P, Daniels I, Gijon M, Boocock D, Coveney C, Miles AK, Shah S, Atabani S, Choudhury RH, Vaghela P, Weston D, Metheringham RL, Brentville VA, Durrant LG. Cook KW, et al. Among authors: durrant lg. J Immunother Cancer. 2021 Jul;9(7):e001910. doi: 10.1136/jitc-2020-001910. J Immunother Cancer. 2021. PMID: 34321274 Free PMC article.

9

Citrullinated Epitopes Identified on Tumour MHC Class II by Peptide Elution Stimulate Both Regulatory and Th1 Responses and Require Careful Selection for Optimal Anti-Tumour Responses.

Symonds P, Marcu A, Cook KW, Metheringham RL, Durrant LG, Brentville VA. Symonds P, et al. Among authors: durrant lg. Front Immunol. 2021 Nov 9;12:764462. doi: 10.3389/fimmu.2021.764462. eCollection 2021. Front Immunol. 2021. PMID: 34858415 Free PMC article.

10

Monoclonal Antibody Targeting Sialyl-di-Lewis^a-Containing Internalizing and Noninternalizing Glycoproteins with Cancer Immunotherapy Development Potential.

Tivadar ST, McIntosh RS, Chua JX, Moss R, Parsons T, Zaitoun AM, Madhusudan S, Durrant LG, Vankemmelbeke M. Tivadar ST, et al. Among authors: durrant lg. Mol Cancer Ther. 2020 Mar;19(3):790-801. doi: 10.1158/1535-7163.MCT-19-0221. Epub 2019 Dec 23. Mol Cancer Ther. 2020. PMID: 31871270

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

184 results

Search Page